Drugmaker Seeks FDA Approval For Over-The-Counter Birth Control

Deutschland Nachrichten Nachrichten

Drugmaker Seeks FDA Approval For Over-The-Counter Birth Control
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 HuffPostWomen
  • ⏱ Reading Time:
  • 67 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 68%

HRA Pharma is making the case that women can safely screen themselves for rare blood clots and that they don't need a prescription.

Many conservative groups stress they are only interested in curtailing abortion, and state bans often explicitly exclude contraception.

In each case, companies must show that consumers can understand the drug’s labeling, evaluate its risks and use it safely and effectively without professional supervision. HRA spent seven years conducting the FDA-required studies, including a trial that followed 1,000 women taking its pill for six months.

Birth control pills are available without a prescription across much of South America, Asia and Africa. Last year, Paris-based HRA won U.K. approval for the first birth control pill available there without a prescription. Most birth control pills contain progestin plus estrogen, which can help make periods lighter and more regular. Progestin-only pills are generally recommended for women who can’t take the more popular combination pills due to health issues.But estrogen also accounts for most of the blood clot risk associated with oral contraceptives. FDA’s labeling warns against their use in certain women already at risk for heart problems, such as those who smoke and are over 35.

“What I definitely see is a misunderstanding of the dangers of these pills. It is much safer to take the pill than to be pregnant” said Dr. Maura Quinlan, a Northwestern University physician and member of the American College of Obstetricians and Gynecologists. She was not involved in HRA’s application or research.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

HuffPostWomen /  🏆 27. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Long Covid Is an Elusive Target for Big PharmaLong Covid Is an Elusive Target for Big PharmaThe drug industry developed Covid-19 vaccines and treatments at breakneck speed, yet treatments for the post-viral illness known as long Covid are nowhere close to being developed.
Weiterlesen »

Drugmaker Seeks FDA Approval of First Over-The-Counter Birth Control PillDrugmaker Seeks FDA Approval of First Over-The-Counter Birth Control PillA drug company is seeking U.S. approval for the first-ever birth control pill that women could buy without a prescription
Weiterlesen »

Over-the-counter birth control? Drugmaker seeks FDA approvalOver-the-counter birth control? Drugmaker seeks FDA approvalHormone-based pills have long been the most common form of birth control in the U.S., used by millions of women since the 1960s. But they have always required a prescription.
Weiterlesen »

Over-the-counter birth control? Drugmaker seeks FDA approvalOver-the-counter birth control? Drugmaker seeks FDA approvalA drug company is seeking U.S. approval for the first birth control pill that women could buy without a prescription
Weiterlesen »

Over-the-counter birth control? Drugmaker seeks FDA approvalOver-the-counter birth control? Drugmaker seeks FDA approvalFor the first time, a pharmaceutical company has asked for permission to sell a birth control pill over the counter in the U.S.
Weiterlesen »

Over-the-counter birth control? Drugmaker seeks FDA approvalOver-the-counter birth control? Drugmaker seeks FDA approvalWASHINGTON (AP) — For the first time, a pharmaceutical company has asked for permission to sell a birth control pill over the counter in the U.S. HRA Pharma’s application on Monday sets up a high-stakes decision for health regulators amid legal and political battles over women’s reproductive health.
Weiterlesen »



Render Time: 2025-03-10 16:26:26